COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India

doi:10.1097/TP.0000000000003835

Comment

. 2021 Sep 1;105(9):e100-e103.

doi: 10.1097/TP.0000000000003835.

COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India

Affiliations

¹ Department of Nephrology and Transplantation Sciences, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.
² Department of Medicine, BJ Medical College, Ahmedabad, Gujarat, India.
³ Department of Transplantation Surgery, IKDRC-ITS, Ahmedabad, Gujarat, India.
⁴ Department of Gynecology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.

PMID: 34049359
PMCID: PMC8384248
DOI: 10.1097/TP.0000000000003835

Comment

COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India

Hari Shankar Meshram et al. Transplantation. 2021.

. 2021 Sep 1;105(9):e100-e103.

doi: 10.1097/TP.0000000000003835.

Affiliations

¹ Department of Nephrology and Transplantation Sciences, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.
² Department of Medicine, BJ Medical College, Ahmedabad, Gujarat, India.
³ Department of Transplantation Surgery, IKDRC-ITS, Ahmedabad, Gujarat, India.
⁴ Department of Gynecology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India.

PMID: 34049359
PMCID: PMC8384248
DOI: 10.1097/TP.0000000000003835

Abstract

formula image

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Comment on

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Boyarsky BJ, et al. JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489. JAMA. 2021. PMID: 33950155 Free PMC article.

Cited by

A Retrospective and Comparative Analysis of Clinical Outcomes of Kidney Transplant Recipients During First and Second COVID-19 Waves in North-West India.
Bhagat C, Gurnani N, Godara S, Mathur R, Goel A, Meshram HS. Bhagat C, et al. Cureus. 2024 Jan 5;16(1):e51693. doi: 10.7759/cureus.51693. eCollection 2024 Jan. Cureus. 2024. PMID: 38313994 Free PMC article.
Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center.
Prasad N, Bansal SB, Yadav B, Manhas N, Yadav D, Gautam S, Kushwaha R, Singh A, Bhadauria D, Yachha M, Behera MR, Kaul A. Prasad N, et al. Front Immunol. 2022 Jun 30;13:911738. doi: 10.3389/fimmu.2022.911738. eCollection 2022. Front Immunol. 2022. PMID: 35844596 Free PMC article.
Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
Meshram HS, Kute VB, Chauhan S, Dave R, Patel H, Banerjee S, Desai S, Kumar D, Navadiya V, Mishra V. Meshram HS, et al. Int Urol Nephrol. 2022 Jul;54(7):1693-1703. doi: 10.1007/s11255-021-03057-5. Epub 2021 Nov 18. Int Urol Nephrol. 2022. PMID: 34792722 Free PMC article.
Consequences of the first and second COVID-19 wave on kidney transplant recipients at a large Indian transplant centre.
Kute VB, Meshram HS, Navadiya VV, Chauhan S, Patel DD, Desai SN, Shah N, Dave RB, Banerjee S, Engineer DP, Patel HV, Rizvi SJ, Mishra VV. Kute VB, et al. Nephrology (Carlton). 2022 Feb;27(2):195-207. doi: 10.1111/nep.13961. Epub 2021 Aug 21. Nephrology (Carlton). 2022. PMID: 34378832 Free PMC article.
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).
Bruminhent J, Setthaudom C, Chaumdee P, Boongird S, Kiertiburanakul S, Malathum K, Nongnuch A, Phuphuakrat A, Jirasiritham S, Janphram C, Thotsiri S, Upama S, Assanatham M; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Am J Transplant. 2022 Mar;22(3):813-822. doi: 10.1111/ajt.16867. Epub 2021 Dec 6. Am J Transplant. 2022. PMID: 34657386 Free PMC article.

See all "Cited by" articles

References

1. Voysey M, Clemens SAC, Madhi SA, et al. ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. - PMC - PubMed
1. Dagan N, Barda N, Kepten E, et al. . BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. - PMC - PubMed
1. Boyarsky BJ, Werbel WA, Avery RK, et al. . Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed
1. Basic-Jukic N, Ivo J. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis. 2021;00:e13628. - PubMed
1. Wadei HM, Gonwa TA, Leoni JC, et al. . COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination. Am J Transplant. [Epub ahead of print. April 23, 2021]. doi:10.1111/ajt.16618 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Voysey M, Clemens SAC, Madhi SA, et al. ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. - PMC - PubMed

[2] Voysey M, Clemens SAC, Madhi SA, et al. ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. - PMC - PubMed

[3] Dagan N, Barda N, Kepten E, et al. . BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. - PMC - PubMed

[4] Dagan N, Barda N, Kepten E, et al. . BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. - PMC - PubMed

[5] Boyarsky BJ, Werbel WA, Avery RK, et al. . Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed

[6] Boyarsky BJ, Werbel WA, Avery RK, et al. . Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed

[7] Basic-Jukic N, Ivo J. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis. 2021;00:e13628. - PubMed

[8] Basic-Jukic N, Ivo J. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis. 2021;00:e13628. - PubMed

[9] Wadei HM, Gonwa TA, Leoni JC, et al. . COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination. Am J Transplant. [Epub ahead of print. April 23, 2021]. doi:10.1111/ajt.16618 - PMC - PubMed

[10] Wadei HM, Gonwa TA, Leoni JC, et al. . COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination. Am J Transplant. [Epub ahead of print. April 23, 2021]. doi:10.1111/ajt.16618 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India

Affiliations

COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India

Authors

Affiliations

Abstract

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical